Latest Articles

This article explores how synthetic biology is revolutionizing therapeutics through engineered cells, precision genetic circuits and AI-driven design, with applications in cancer treatment, vaccine development and next-generation immunotherapies.

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle diseases that medicines can’t, helping fight cancer, genetic disorders and even infectious diseases.

Professor Franka Kalman shares insights on the journey that has led to be a successful and celebrated separation scientist, the people who have inspired and supported her along the way and how she’s helping the next generation of female scientists.

Drug discovery efforts have expanded beyond the traditional approaches of small molecules and antibodies to include cells. This article explores the use of microfluidic methods for high-throughput screening of cell-based drug products.

Discover how RNA therapeutics are reshaping medicine, offering new treatments for previously undruggable targets.

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and reducing errors.

This article discusses the mechanisms of bacterial transduction and how scientists can utilize it to manipulate bacterial genomes for a wide variety of purposes.

Immuno-oncology and cell-based treatments, which harness the body's own immune system to combat illnesses like cancer, have emerged as some of the most promising areas of study. This article explores how cell therapy is evolving.

This article will cover the basic theory behind logistic regression, the types of logistic regression, when to use them and take you through a worked example.

Scientists warn that the NIH’s 15% cap on indirect costs could threaten research funding. Learn why this policy is under fire.